THALLOUS CHLORIDE TI-201 INJECTION SOLUTION

Țară: Canada

Limbă: engleză

Sursă: Health Canada

Ingredient activ:

THALLIUM CHLORIDE(TI 201)

Disponibil de la:

CURIUM CANADA INC

Codul ATC:

V09GX01

INN (nume internaţional):

THALLIUM 201 TL CHLORIDE

Dozare:

37MBq

Forma farmaceutică:

SOLUTION

Compoziție:

THALLIUM CHLORIDE(TI 201) 37MBq

Calea de administrare:

INTRAVENOUS

Unități în pachet:

10ML

Tip de prescriptie medicala:

Schedule C

Zonă Terapeutică:

ROENTGENOGRAPHY

Rezumat produs:

Active ingredient group (AIG) number: 0152598004; AHFS:

Statutul autorizaţiei:

APPROVED

Data de autorizare:

2018-12-07

Caracteristicilor produsului

_Page 1 of 21 _
PRODUCT MONOGRAPH
THALLOUS CHLORIDE TL 201 INJECTION
Thallium Tl 201
Solution for intravenous use containing per mL, 37 megabecquerels (1
millicurie)
Thallous Chloride Tl 201 at calibration time.
Radiodiagnostic Agent
Curium Canada Inc.
2572 boul. Daniel-Johnson, Suite 245-249
Laval, QC, H7T-2R3
CANADA
Date of Revision: April 26
th
, 2019
CONTROL NUMBER: 225111
_Page 2 of 21 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
DESCRIPTION...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
5
CONTRAINDICATIONS
..................................................................................................
6
WARNINGS AND PRECAUTIONS
.................................................................................
6
ADVERSE REACTIONS
...................................................................................................
9
DRUG INTERACTIONS
...................................................................................................
9
DOSAGE AND ADMINISTRATION
.............................................................................
10
RADIATION DOSIMETRY
............................................................................................
12
OVERDOSAGE
...............................................................................................................
13
ACTION AND CLINICAL PHARMACOLOGY
........................................................... 13
STORAGE AND STABILITY
.........................................................................................
14
SPECIAL HANDLING INSTRUCTIONS
......................................................................
15
DOSAGE FORMS, COMPOSITION AND PACKAGING
.......................